Drug Shortage Report for APO-NAPROXEN EC

Last updated on 2022-01-14 History
Report ID 152770
Drug Identification Number 02246700
Brand name APO-NAPROXEN EC
Common or Proper name NAPROXEN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) NAPROXEN
Strength(s) 375MG
Dosage form(s) TABLET (ENTERIC-COATED)
Route of administration ORAL ORAL
Packaging size 100 BTL
ATC code M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-01-10
Estimated end date 2022-01-25
Actual end date
Shortage status Actual shortage
Updated date 2022-01-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2022-01-14 French Compare
v1 2022-01-14 English Compare

Showing 1 to 2 of 2